A standard semen analysis measures semen volume, sperm concentration, total sperm number, motility and morphology against the WHO 6th-edition 2021 reference values — 1.4 mL, 16 million/mL, 39 million total, 42% total motility and 4% normal forms — and costs about $50-$300 in the United States. One abnormal result is never a diagnosis: a second sample, with the same 4-5 day abstinence interval, is standard.
Why Is a Semen Analysis the First Male Fertility Test?
After 1 year of trying (or 6 months if the female partner is over 35), the first test a clinic orders for the male partner is a semen analysis, the most informative screening test in male fertility.
Infertility affects an estimated 15% of couples worldwide, and male factors are involved in roughly half — the sole cause in about 20% of cases and a contributing cause in another 30% — Boitrelle et al., 2021. “The female partner was already tested, so the male can skip it” is a costly mistake.
Is Sperm Count Actually Declining?
Yes, and it is accelerating. A meta-analysis in Human Reproduction Update pooled 223 studies and 288 estimates from 1973 to 2018: average sperm concentration in unselected men fell 51.6% over 45 years, about 1.17% per year — Levine et al., 2023.
Restricted to samples after 2000, the slope steepens to −1.73% per year, from 1.16% (post-1972) to 2.64% (post-2000); total sperm number fell 62.3% overall, roughly 4.7 million fewer per year.
What Does a Semen Analysis Measure?
A standard report contains seven parameters, each with an internationally agreed lower reference limit.
| Parameter | What it measures | WHO 2021 (6th ed) lower limit | WHO 2010 (5th ed) |
|---|---|---|---|
| Semen volume | Volume per ejaculate | 1.4 mL (1.3-1.5) | 1.5 mL |
| Sperm concentration | Sperm per mL | 16 million/mL | 15 million/mL |
| Total sperm number | Concentration × volume | 39 million (35-40 M) | 39 million |
| Total motility | Sperm moving at all | 42% (40-43) | 40% |
| Progressive motility | Straight-line swimming | 30% (29-31) | 32% |
| Normal morphology | Normal head, midpiece, tail | 4% (3.9-4) | 4% |
| Vitality | Live sperm (if motility is low) | 54% (50-56) | 58% |
Both editions’ values are the 5th percentile of men from couples who conceived naturally within 12 months of unprotected sex — the worst 5% of a fertile population, not a line between healthy and unhealthy — Boitrelle et al., 2021.
What Happens When Values Fall Below the Reference Range?
A 2026 prospective study from the PRESTO conception-tracking cohort followed 763 North American men and 1,376 semen samples; 80.7% of the couples conceived within 12 cycles.
A fecundability ratio (FR) below 1 means reduced per-cycle odds; parentheses are 95% confidence intervals. Against the exact WHO 2021 cutoffs:
- Low total sperm number (≤39 million): FR 0.58 (95% CI 0.38-0.88) — roughly 42% lower per-cycle conception probability.
- Low concentration (≤16 million/mL): FR 0.74 (95% CI 0.56-0.97).
- Low motility (≤42%): FR 0.98 (95% CI 0.81-1.19), not statistically significant.
- Low total motile count (≤21 million): FR 0.73 (95% CI 0.52-1.04).
- Low semen volume (≤1.5 mL): FR 1.48 (95% CI 1.05-2.08) — the only parameter not tied to reduced fecundability in this cohort — Lovett et al., 2026.
Sperm number predicts natural conception more strongly than motility; at IUI (intrauterine insemination) or IVF (in vitro fertilization), motility becomes critical, because the lab selects sperm by movement.
What Changed in the WHO 6th Edition of 2021?
Three changes in the 2021 manual alter how you read a report:
- Reference values are no longer diagnostic cutoffs. The 5th-percentile limits are one way to read an analysis; no single cutoff diagnoses male infertility — Boitrelle et al., 2021.
- Motility returns to four categories (rapid progressive, slow progressive, non-progressive, immotile) — more laboratory work, richer information.
- Vitality testing is recommended when total motility falls below 40%, separating “not moving” from “dead”.
It also aligns with laboratory standard ISO 23162:2021, harmonizing semen testing worldwide — Björndahl & Kirkman Brown, 2022.
How Is a Semen Analysis Performed?
Four steps — preparation, sampling, laboratory analysis, reporting — two of them where patients most often lose accuracy.
Step 1: Preparation — 2-5 Days of Abstinence
The WHO manual requires 2-5 days of abstinence: too short suppresses volume and count, too long raises dead and immotile sperm.
For the second sample, a 2023 study of 3,456 subfertile men recommends keeping abstinence at 4-5 days and identical between tests. Two details patients miss:
- Report any fever, sauna or hot-tub exposure in the past 2-3 months. A fever two months ago can still depress today’s numbers.
- Bring a medication list. Testosterone, certain antibiotics, finasteride, chemotherapy and some antidepressants or opioids all shift semen parameters.
Step 2: Collecting the Sample
Most clinics ask for the sample on site, in a private room, into a sterile container. At home, it must reach the lab within about 1 hour and stay near body temperature — an inside pocket, not a glovebox or fridge.
Step 3: Laboratory Analysis
The lab measures volume, counts sperm in a chamber (or with a computer-assisted analyzer), assesses motility at 37 °C and grades morphology on a stained smear; below 40% total motility, a vitality stain is added.
Motility assessment is partly subjective, so between-lab variation is real: compare results from the same laboratory.
Step 4: Getting Your Results
Results usually arrive within 1-3 business days. Ask for the raw numbers, not just “normal” or “abnormal”, and if IUI is on the table, the written post-wash count — not the raw count — decides what is possible.
How Do You Read a Semen Analysis Report?
The report labels each low parameter with a named condition — a description of the sample, not the person.
| Report term | Meaning | Triggered when |
|---|---|---|
| Oligozoospermia | Low sperm concentration | Below ~16 million/mL |
| Asthenozoospermia | Low sperm motility | Total motility below ~42% |
| Teratozoospermia | Low share of normal forms | Morphology below ~4% |
| OAT syndrome | All three low at once | Oligo + astheno + teratozoospermia |
| Azoospermia | No sperm in the ejaculate | None found even after centrifugation |
| Cryptozoospermia | Sperm present, in traces only | A few found only after centrifugation |
Why Is One Abnormal Result Not a Diagnosis?
Because natural fluctuation is genuinely large. A 2023 study in Andrology of repeated samples from 3,456 subfertile men found significant spontaneous variation, most pronounced in young men with normal testicular volume and oligozoospermic counts.
Interpretation should rest on two samples, with abstinence at 4-5 days before each — PMID 36908159. The pathway is first sample → repeat 4-6 weeks later at the same interval → judge the two together, never one number.
How Much Does a Semen Analysis Cost?
Published self-pay prices from US hospital, commercial and clinic andrology labs run $50-$300 per sample, making this one of the cheapest fertility tests.
At-home counters are cheaper but measure fewer parameters — usually concentration only, sometimes motility — so they screen rather than replace a full analysis. A cost-effectiveness analysis in Urology found home testing could be a cost-effective way to screen for oligozoospermia, provided abnormal results are confirmed in a clinic laboratory — PMID 36115433.
Will Insurance Cover a Semen Analysis?
In the United States, a diagnostic semen analysis ordered during an infertility workup is usually reimbursable under commercial plans: it counts as diagnosis, not treatment. Coverage still varies by plan and state, and IVF mandates do not always cover diagnostic items — see our IVF insurance guide.
If you are paying cash, ask for the self-pay price first: listed prices exceed what uninsured patients actually pay. The real money is in add-ons — DNA fragmentation, sperm antibodies and oxidative-stress panels are billed separately and often excluded — so ask whether a test will change your treatment plan.
When a Standard Semen Analysis Is Not Enough: DNA Fragmentation
A standard analysis measures what sperm look like and how they swim, not whether their DNA is intact — which explains a familiar picture: normal parameters, yet repeated fertilization failure or recurrent miscarriage.
What Does the DNA Fragmentation Evidence Show?
The largest synthesis is a 2026 umbrella meta-analysis of 8 meta-analyses and more than 25,000 assisted reproduction cycles, linking high DNA fragmentation to significantly lower clinical pregnancy rates. A risk ratio (RR) below 1 means the high-fragmentation group conceived less often:
- IVF: RR 0.662 (95% CI 0.547-0.801)
- IUI: RR 0.467 (95% CI 0.242-0.900)
- ICSI (intracytoplasmic sperm injection): RR 0.886 (95% CI 0.764-0.985) — a much weaker, borderline association — Wan et al., 2026
The gradient is clinically meaningful: ICSI bypasses most of the sperm-selection problem high fragmentation creates in IVF and IUI. A second 2026 cohort study of 320 men with asthenozoospermia and 100 controls found lower fertilization, clinical pregnancy and live-birth rates in the high-fragmentation group — PMID 42100189.
Who Should Consider Extra Testing?
Advanced testing is discussed when at least one applies: recurrent pregnancy loss, unexplained IVF failure or poor fertilization, varicocele (especially grade III), prior genital-tract infection, chemotherapy or heat exposure — not a first-line test for every couple.
The 2024 amended AUA (American Urological Association)/ASRM guideline also revised Y-chromosome microdeletion thresholds and testicular sperm recommendations. Azoospermia and severe oligozoospermia now trigger a structured genetic workup, not just “retest again” — AUA/ASRM, 2024.
What Should You Do With an Abnormal Result?
An abnormal result is a fork, not an endpoint: the path depends on the abnormality’s type and severity and on the female partner’s age.
Step 1: Retest Before Deciding Anything
Two samples, the same abstinence interval, ideally the same laboratory: many “abnormal” first results normalize on the second test, and only a repeat abnormality is a real signal.
Step 2: Lifestyle, Medication Review and Antioxidants
Sperm take roughly 2-3 months from production to ejaculation, so judge any lifestyle change at a 3-month retest. Smoking, heavy alcohol, obesity, heat exposure and untreated varicocele are the highest-yield targets.
Antioxidants are widely used with limited support. A 2022 Cochrane review pooled 90 studies and 10,303 subfertile men and found they may increase live birth (OR 1.43, 95% CI 1.07-1.91) and clinical pregnancy (OR 1.89, 95% CI 1.45-2.47), but graded the certainty very low to low — Cochrane 2022.
“In this review, there is very low-certainty evidence from 12 small or medium-sized randomised controlled trials suggesting that antioxidant supplementation in subfertile males may improve live birth rates for couples attending fertility clinics.” — de Ligny et al., Antioxidants for Male Subfertility, Cochrane Database of Systematic Reviews, 2022
Treat antioxidants as a low-risk attempt, not a treatment.
Step 3: Match the Treatment Path to the Result Type
| Result pattern | Usual first option | Why |
|---|---|---|
| Mild oligozoospermia, normal motility | IUI with washed sperm | Motile sperm placed past the cervix; usually 3-4 cycles tried |
| Moderate/severe oligozoospermia or poor motility | IVF with ICSI | ICSI injects one selected sperm per egg, bypassing motility |
| High DNA fragmentation after IVF failure | ICSI ± sperm selection or testicular sperm | ICSI blunts the impact of DNA damage; testicular sperm typically fragment less |
| Azoospermia (no sperm in ejaculate) | micro-TESE + ICSI | Surgical sperm retrieval succeeds in about half of non-obstructive cases |
Compare the first two paths in our IUI vs IVF comparison guide; the full male-factor ladder is in our male infertility and IVF guide.
What If the Sample Contains No Sperm at All?
Azoospermia is the result couples fear most, and its data are more encouraging than expected. A systematic review in Human Reproduction Update pooled 117 studies and 21,404 men with non-obstructive azoospermia.
The retrieval rate per testicular sperm extraction (TESE) was 47% (95% CI 45-49%), with cumulative clinical pregnancy of 29% (95% CI 25-32%) and live birth of 24% (95% CI 20-28%) per ICSI cycle; fresh versus frozen testicular sperm gave 35% vs 20% clinical pregnancy and 30% vs 20% live birth (not statistically confirmed) — Corona et al., 2019.
Three Abnormal Results, Three Different Patient Paths
Patient stories are shared with consent; names and identifying details have been changed to protect privacy, and all clinical figures reflect the sources cited above.
Case 1: David and Rachel — Low Count, Otherwise Healthy Life
David, 38, had a first analysis of 12 million/mL and 24 million total — below the WHO 2021 lines of 16 million/mL and 39 million. A Chicago consultant, he drank three or four coffees a day, cycled 100 km a week and took one blood-pressure medication.
A retest 5 days after the previous ejaculation gave 14 million/mL. His urologist reviewed his medication, stopped the sauna sessions and set a 3-month antioxidant plan.
“Nobody told me one test doesn’t count,” David said. “The second test reset how serious this was, and the three-month wait at least made sense.”
By month 4 his total count had risen to 38 million — just under the WHO line, but 58% above the first sample. Three IUI cycles failed; the first IVF/ICSI transfer ended in a live birth, at about $14,000 for all four cycles.
Case 2: Wei, 35 — Severe Oligozoospermia, ICSI Abroad
Wei, a Hangzhou engineer, had severe oligozoospermia (2.8 million/mL) with only 1.5% normal forms across two tests six weeks apart. His wife, 33, had a normal ovarian reserve.
At that severity, with little room for repeated IUI attempts, they went straight to a clinic in Thailand for IVF with ICSI. The medicated cycle cost roughly 220,000 baht (about $6,300), less than half the quoted US price.
“I assumed low count meant donor sperm,” Wei said. “The doctor showed us the fertilization report: 6 eggs, 4 fertilized by ICSI, 2 blastocysts. We transferred one.”
The fresh transfer achieved a healthy pregnancy; the second blastocyst remains frozen.
Case 3: Ahmed, 33 — Zero Sperm, Then micro-TESE
Ahmed, a 33-year-old accountant in Dubai, was told he had azoospermia — no sperm in two samples. His hormone panel showed elevated FSH (follicle-stimulating hormone), and his urologist recommended micro-TESE.
“When the clinic said ‘zero’, I stopped hearing the rest,” he said. “It took me two weeks to understand that zero in the ejaculate is not zero in the testicle.”
Micro-TESE found sperm, consistent with the pooled ~47% retrieval rate. The first ICSI cycle failed; a second, frozen-embryo transfer worked, at an all-in cost of about $18,000 including surgery and two ICSI cycles.
FAQ
Q: What sperm count is considered normal?
The WHO 2021 lower reference limits are 39 million total sperm and 16 million per milliliter — 5th-percentile values from men who conceived naturally, not a pass mark; in the PRESTO cohort 80.7% of couples conceived within 12 cycles.
Q: How long does a semen analysis take, and when do results come back?
Laboratory analysis takes about 1 hour per sample and most clinics report within 1-3 business days; if IUI is planned, also request the post-wash count, which drives the treatment decision.
Q: How much does a semen analysis cost?
Typically $50-$300 in the United States in a hospital, commercial or clinic andrology lab; at-home tests measure fewer parameters, and any abnormal result still needs laboratory confirmation.
Q: Does insurance cover a semen analysis?
As a diagnostic part of an infertility workup it is usually reimbursable under US commercial plans, though add-ons such as DNA fragmentation are commonly excluded; if coverage is denied, the $50-$300 self-pay price often beats an appeal.
Q: Can sperm count be improved?
Sometimes: sperm need 2-3 months to mature, so judge a lifestyle change at a 3-month retest. Antioxidant evidence is very low certainty (see the Cochrane review above), so expect limited improvement, not reversal.
Q: Does low motility automatically mean IVF?
No. Mild motility problems are usually managed first with washed-sperm IUI, which concentrates the moving fraction.
Moderate-to-severe problems or elevated DNA fragmentation point toward IVF with ICSI: high fragmentation left the clinical pregnancy risk ratio at 0.467 for IUI but 0.886 for ICSI.
Q: My partner’s test showed zero sperm. What happens next?
First the doctor separates obstructive from non-obstructive azoospermia and orders genetic and hormone testing. Surgery is far from futile: across 117 pooled studies and 21,404 men with non-obstructive azoospermia, sperm were found in 47% of TESE procedures, with a 24% cumulative live-birth rate per ICSI cycle.
Zero in the ejaculate is a serious finding, not the end of the pathway.
Q: Do I really need a second test?
Yes — standard practice, not excess caution: a 2023 study of 3,456 men concluded that results must be judged from two samples with a consistent 4-5 day abstinence interval, because a single test can mislabel a man in either direction.
How to Plan Your Next Step
A semen analysis is the cheapest, fastest way to learn whether — and what kind of — treatment the male partner needs. Three things to keep:
- Test early. Male factors contribute to about 50% of infertility cases.
- Read two samples, not one, at the same 4-5 day abstinence interval, ideally in the same laboratory.
- Match treatment to result type — IUI for mild problems, IVF with ICSI for severe ones, retrieval plus ICSI when there is no sperm.
Success data come from the CDC assisted reproductive technology program, clinic-level figures from SART and guidance from ASRM; to compare clinics at home or abroad, browse verified hospital profiles or contact the ProIVF team.
About this article: Researched and written by the ProIVF Medical Editorial Team from the WHO Laboratory Manual (6th edition), CDC ART reports, ASRM and SART data, and peer-reviewed PubMed studies, with AI-assisted tools used only for literature organization and initial drafting under editorial direction. Reviewed by the ProIVF Medical Advisory Board; our editorial standards are on our About page.
Last updated: September 11, 2026. Informational only, not medical advice: results must be interpreted by a licensed reproductive or urological specialist alongside your full medical history, and population reference values cannot predict individual outcomes.
